Predicting asthma in preschool children with asthma symptoms: study rationale and design

BMC Pulmonary Medicine

Hein Raat⁴  Johan C de Jongste¹  Ewout W Steyerberg⁴  Vincent WV Jaddoe³  Alet Wijga²  Daan Caudri¹  Hester F Lingsma⁴  Esther Hafkamp-de Groen⁴ 

[1] Department of Paediatrics, Division of Respiratory Medicine, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands;Centre for Prevention and Health Services Research / National Institute for Public Health and the Environment, Bilthoven, The Netherlands;Department of Paediatrics, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands;Department of Public Health, Erasmus MC, Rotterdam, The Netherlands

关键词: Well-child care;    Prediction;    External validation;    Children;    Asthma Risk Appraisal Tool;   

Others  :  1136344
DOI  :  10.1186/1471-2466-12-65

 received in 2012-09-25, accepted in 2012-10-12,  发布年份 2012

【 摘 要 】

Background

In well-child care it is difficult to determine whether preschool children with asthma symptoms actually have or will develop asthma at school age. The PIAMA (Prevention and Incidence of Asthma and Mite Allergy) Risk Score has been proposed as an instrument that predicts asthma at school age, using eight easy obtainable parameters, assessed at the time of first asthma symptoms at preschool age. The aim of this study is to present the rationale and design of a study 1) to externally validate and update the PIAMA Risk Score, 2) to develop an Asthma Risk Appraisal Tool to predict asthma at school age in (specific subgroups of) preschool children with asthma symptoms and 3) to test implementation of the Asthma Risk Appraisal Tool in well-child care.

Methods and design

The study will be performed within the framework of Generation R, a prospective multi-ethnic cohort study. In total, consent for postnatal follow-up was obtained from 7893 children, born between 2002 and 2006. At preschool age the PIAMA Risk Score will be assessed and used to predict asthma at school age. Discrimination (C-index) and calibration will be assessed for the external validation. We will study whether the predictive ability of the PIAMA Risk Score can be improved by removing or adding predictors (e.g. preterm birth). The (updated) PIAMA Risk Score will be converted to the Asthma Risk Appraisal Tool- to predict asthma at school age in preschool children with asthma symptoms. Additionally, we will conduct a pilot study to test implementation of the Asthma Risk Appraisal Tool in well-child care.

Discussion

Application of the Asthma Risk Appraisal Tool in well-child care will help to distinguish preschool children at high- and low-risk of developing asthma at school age when asthma symptoms appear.

This study will increase knowledge about the validity of the PIAMA risk score and might improve risk assessment of developing asthma at school age in (specific subgroups of) preschool children, who present with asthma symptoms at well-child care.

【 授权许可】

   
2012 Hafkamp-de Groen et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Martinez FD: What have we learned from the Tucson Children’s Respiratory Study? Paediatr Respir Rev 2002, 3:193-197.
• [2]Caudri D, Wijga AH, Smit HA, Koppelman GH, Kerkhof M, Hoekstra MO, Brunekreef B, de Jongste JC: Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment. Pediatr Allergy Immunol 2011, 22:652-659.
• [3]Buijze H, Jawad J, van der Kort G, Korthuis SE, van der Lei J, Mink M, Nijendaal G, Potting SMC, Roest E, Schilthuis HJ, et al.: Evaluatie Jeugdgezondheidszorg 2006. Leiden: TNO and Van Naem & Partners; 2006.
• [4]Hafkamp-de Groen E, Mohangoo AD, de Jongste JC, Van der Wouden JC, Moll HA, Jaddoe VW, Hofman A, de Koning HJ, Raat H: Early detection and counselling intervention of asthma symptoms in preschool children: study design of a cluster randomised controlled trial. BMC Publ Health 2010, 10:555. BioMed Central Full Text
• [5]Balemans WA, van der Ent CK, Schilder AG, Sanders EA, Zielhuis GA, Rovers MM: Prediction of asthma in young adults using childhood characteristics: Development of a prediction rule. J Clin Epidemiol 2006, 59:1207-1212.
• [6]Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD: A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000, 162:1403-1406.
• [7]Caudri D, Wijga A, Schipper CM, Hoekstra M, Postma DS, Koppelman GH, Brunekreef B, Smit HA, de Jongste JC: Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol 2009, 124:903-910. e901-907.
• [8]Devulapalli CS, Carlsen KC, Haland G, Munthe-Kaas MC, Pettersen M, Mowinckel P, Carlsen KH: Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax 2008, 63:8-13.
• [9]Eysink PE, ter Riet G, Aalberse RC, van Aalderen WM, Roos CM, van der Zee JS, Bindels PJ: Accuracy of specific IgE in the prediction of asthma: development of a scoring formula for general practice. Br J Gen Pract 2005, 55:125-131.
• [10]Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH: Predicting persistent disease among children who wheeze during early life. Eur Respir J 2003, 22:767-771.
• [11]Matricardi PM, Illi S, Gruber C, Keil T, Nickel R, Wahn U, Lau S: Wheezing in childhood: incidence, longitudinal patterns and factors predicting persistence. Eur Respir J 2008, 32:585-592.
• [12]Wever-Hess J, Kouwenberg JM, Duiverman EJ, Hermans J, Wever AM: Prognostic characteristics of asthma diagnosis in early childhood in clinical practice. Acta Paediatr 1999, 88:827-834.
• [13]Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Uitterlinden AG, Verhulst FC, Hofman A: The Generation R Study: design and cohort update 2010. Eur J Epidemiol 2010, 25:823-841.
• [14]Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, et al.: International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995, 8:483-491.
• [15]Sole D, Vanna AT, Yamada E, Rizzo MC, Naspitz CK: International Study of Asthma and Allergies in Childhood (ISAAC) written questionnaire: validation of the asthma component among Brazilian children. J Investig Allergol Clin Immunol 1998, 8:376-382.
• [16]Vergouwe Y, Moons KG, Steyerberg EW: External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients. Am J Epidemiol 2010, 172:971-980.
• [17]Leonardi NA, Spycher BD, Strippoli MP, Frey U, Silverman M, Kuehni CE: Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. J Allergy Clin Immunol 2011, 127:1466-1472. e1466.
• [18]Dusseldorp E, Boere-Boonekamp MM, Coenen-Van Vroonhoven E: Pilotstudie D-screening: screening op ontwikkelingsachterstand bij het jonge kind, uitgevoerd door de jeugdarts. Leiden: TNO; 2011.
• [19]Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD: Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol 2005, 58:475-483.
• [20]Van den Boom G: Early detection and medical treatment of asthma and COPD in general practice [PhD Thesis]. Katholieke Universiteit Nijmegen: University Press Nijmegen; 2000.